Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Lenalidomide (CC-5013)
DRUG
2 trials
Sponsors
Celgene Corporation
, Southern Europe New Drug Organization
Conditions
Advanced Solid Tumors
Radiculopathy
Phase 1
Lenalidomide and Paclitaxel in Advanced Solid Tumors
NCT01155505
Southern Europe New Drug Organization
Advanced Solid Tumors
Start: 2009-11-30
End: 2012-03-31
Target: 28
Updated: 2011-09-13
Phase 2
Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Painful Lumbar Radiculopathy
Completed
NCT00120120
Celgene Corporation
Radiculopathy
Start: 2005-01-31
End: 2007-11-30
Updated: 2009-09-23
Related Papers
A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase
Pain Medicine
2016-08-19
3 citations